Drugs / CBD
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT05170451 Comparator | Jan → Jun 2022 | musculoskeletal system disorder | University of Virginia | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05170451 ↗ |
| Route | Topical | “Topical CBD 50 mg/ml applied in 1mL amounts twice daily” NCT05170451 ↗ |